Related Experiment Video
Updated: Jul 19, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Is glycemic variability important to assessing antidiabetes therapies?
1University of Virginia Health System, Box 800137, Charlottesville, VA 22908, USA. boris@virginia.edu
Abstract:
Traditionally, statistical estimation of glycemic variability includes computing standard deviation of glucose readings or related statistics (eg, M value, mean amplitude of glucose excursions, and so forth). We advocate an alternative approach using risk measures of variability, which have substantial clinical and numerical advantages. In addition, continuous glucose monitoring (CGM) data have clinically important inherent temporal structure that should be taken into consideration. Thus, temporal variability methods are discussed for the analysis and interpretation of CGM output.
Related Concept Videos
Hyperglycemia
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Variability: Analysis
The range is a simple measure of variability, indicating the difference between the highest and...
Diabetes Mellitus: Type 2 and Gestational
Hypoglycemia and Glucagon